Analyst consensus rating
Nutex Health Analyst Rating: Strong Buy
NUTX is rated Strong Buy by 5 analysts with a $266.40 target. As of 2026-08-17.
Direct answer
Nutex Health's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $266.40.
Forecast evidence checked August 17, 2026.
Get free Nutex Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $187.42
- Average price target
- $266.40
- High price target
- $310.00
- Low price target
- $200.00
- Low target gap
- +6.7%
- Target upside
- +42.1%
- High target gap
- +65.4%
- Target range width
- 58.7%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 17, 2026
- Valid through
- August 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Nutex Health?
Nutex Health has a verified Strong Buy consensus. The same dataset has an average price target of $266.40.
How far are Nutex Health's low and high targets from the recorded price?
The low target implies +6.7%, while the high target implies +65.4%.
How many analysts are included in Nutex Health's consensus?
The verified consensus includes 5 analysts.
How is Nutex Health's target upside or downside calculated?
The average target of $266.40 is divided by the recorded price of $187.42, then one is subtracted to produce +42.1%. This does not guarantee a future return.
When was Nutex Health's analyst forecast verified?
The data was verified on 2026-08-17. The dataset is valid through 2026-08-24.